These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

885 related items for PubMed ID: 27487436

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Infection due to C. difficile ribotype 078: first report of cases in the Republic of Ireland.
    Burns K, Morris-Downes M, Fawley WN, Smyth E, Wilcox MH, Fitzpatrick F.
    J Hosp Infect; 2010 Aug; 75(4):287-91. PubMed ID: 20621236
    [Abstract] [Full Text] [Related]

  • 23. Epidemiology of community-onset Clostridium difficile infection in a community in the South of England.
    Fellmeth G, Yarlagadda S, Iyer S.
    J Infect Public Health; 2010 Aug; 3(3):118-23. PubMed ID: 20869672
    [Abstract] [Full Text] [Related]

  • 24. Analysis of prevalence, risk factors and molecular epidemiology of Clostridium difficile infection in Kuwait over a 3-year period.
    Jamal W, Rotimi VO, Brazier J, Duerden BI.
    Anaerobe; 2010 Dec; 16(6):560-5. PubMed ID: 20887795
    [Abstract] [Full Text] [Related]

  • 25. Association of healthcare exposure with acquisition of different Clostridium difficile strain types in patients with recurrent infection or colonization after clinical resolution of initial infection.
    Thabit AK, Housman ST, Burnham CD, Nicolau DP.
    J Hosp Infect; 2016 Feb; 92(2):167-72. PubMed ID: 26792686
    [Abstract] [Full Text] [Related]

  • 26. Occurrence of Clostridium difficile ribotype 027 in hospitals of Silesia, Poland.
    Aptekorz M, Szczegielniak A, Wiechuła B, Harmanus C, Kuijper E, Martirosian G.
    Anaerobe; 2017 Jun; 45():106-113. PubMed ID: 28216085
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clostridium difficile ribotype 176 - A predictor for high mortality and risk of nosocomial spread?
    Polivkova S, Krutova M, Petrlova K, Benes J, Nyc O.
    Anaerobe; 2016 Aug; 40():35-40. PubMed ID: 27155489
    [Abstract] [Full Text] [Related]

  • 33. Clinical Characteristics and Treatment Outcomes of Clostridium difficile Infections by PCR Ribotype 017 and 018 Strains.
    Kim J, Kim Y, Pai H.
    PLoS One; 2016 Aug; 11(12):e0168849. PubMed ID: 28002482
    [Abstract] [Full Text] [Related]

  • 34. In the Endemic Setting, Clostridium difficile Ribotype 027 Is Virulent But Not Hypervirulent.
    Aitken SL, Alam MJ, Khaleduzzaman M, Walk ST, Musick WL, Pham VP, Christensen JL, Atmar RL, Xie Y, Garey KW.
    Infect Control Hosp Epidemiol; 2015 Nov; 36(11):1318-23. PubMed ID: 26288985
    [Abstract] [Full Text] [Related]

  • 35. Clinical and microbiological characteristics of community-onset Clostridium difficile infection in The Netherlands.
    Bauer MP, Veenendaal D, Verhoef L, Bloembergen P, van Dissel JT, Kuijper EJ.
    Clin Microbiol Infect; 2009 Dec; 15(12):1087-92. PubMed ID: 19624512
    [Abstract] [Full Text] [Related]

  • 36. Examining the epidemiology and microbiology of Clostridium difficile carriage in elderly patients and residents of a healthcare facility in southern Ontario, Canada.
    Mallia G, Van Toen J, Rousseau J, Jacob L, Boerlin P, Greer A, Metcalf D, Weese JS.
    J Hosp Infect; 2018 Aug; 99(4):461-468. PubMed ID: 29408207
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel.
    Miller-Roll T, Na'amnih W, Cohen D, Carmeli Y, Adler A.
    Diagn Microbiol Infect Dis; 2016 Dec; 86(4):450-454. PubMed ID: 27638350
    [Abstract] [Full Text] [Related]

  • 39. The ClosER study: results from a three-year pan-European longitudinal surveillance of antibiotic resistance among prevalent Clostridium difficile ribotypes, 2011-2014.
    Freeman J, Vernon J, Pilling S, Morris K, Nicholson S, Shearman S, Longshaw C, Wilcox MH, Pan-European Longitudinal Surveillance of Antibiotic Resistance among Prevalent Clostridium difficile Ribotypes Study Group.
    Clin Microbiol Infect; 2018 Jul; 24(7):724-731. PubMed ID: 29066403
    [Abstract] [Full Text] [Related]

  • 40. Surveillance of Antibiotic Resistance among Hospital- and Community-Acquired Toxigenic Clostridium difficile Isolates over 5-Year Period in Kuwait.
    Jamal WY, Rotimi VO.
    PLoS One; 2016 Jul; 11(8):e0161411. PubMed ID: 27536994
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 45.